<DOC>
	<DOCNO>NCT01968928</DOCNO>
	<brief_summary>Bladder urothelial carcinoma ( UC ) common malignancy incidence increase year Taiwan . Chemoresistance inevitable treatment metastatic disease lead ominous outcome . To develop novel therapeutic strategy overcome chemoresistance imperative . Cancer cell uptake glucose high rate normal tissue use glucose glycolysis even normoxia condition , know Warburg effect . Pyruvate kinase ( PK ) catalyze last step process glycolysis , one isoform -- PKM2 report associated tumor progression specific tissue promote Warburg effect cancer cell .</brief_summary>
	<brief_title>The Role Pyruvate Kinase M2 Growth , Invasion Drug Resistance Human Urothelial Carcinoma</brief_title>
	<detailed_description>Regulation PKM2 novel target cancer therapy . Meanwhile , PKM2 may play critical role development drug resistance promise target overcome drug resistance . In study , specific aim follow : 1 . To prove differentia expression level PKM2 UC cell drug-resistant UC cell , well human UC tissue drug-resistant UC tissue . 2 . To examine effect PKM2 regulations（PKM2 siRNA shikonin）on invasiveness metastatic ability UC cell clarify role PKM2 human UC cell . 3 . To investigate combinatory effect PKM2 regulations（PKM2 siRNA shikonin）and currently use chemotherapeutic agent ( cisplatin，gemcitabine , doxorubicin ) . Do PKM2 regulation enhance cytotoxic effect chemotherapy overcome chemoresistance？ 4 . To prove vitro finding nude mouse xenograft model。</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Transitional Cell</mesh_term>
	<criteria>patient age 2080 year old take Radical Cystectomy nephrectomy 20082012 patient age locate interval 2080 year old .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Bladder urothelial carcinoma ( UC )</keyword>
	<keyword>pyruvate kinase</keyword>
	<keyword>drug resistance</keyword>
	<keyword>shikonin</keyword>
</DOC>